Lombard Odier Asset Management (Europe)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,000
| Closed | -$434K | – | 281 |
|
|
2024
Q1 | $434K | Hold |
50,000
| – | – | 0.03% | 204 |
|
|
2023
Q4 | $328K | Buy |
50,000
+15,000
| +43% | +$98.3K | 0.02% | 211 |
|
|
2023
Q3 | $350K | Hold |
35,000
| – | – | 0.02% | 227 |
|
|
2023
Q2 | $435K | Sell |
35,000
-2,000
| -5% | -$24.9K | 0.02% | 229 |
|
|
2023
Q1 | $518K | Sell |
37,000
-3,000
| -8% | -$42K | 0.03% | 247 |
|
|
2022
Q4 | $572K | Sell |
40,000
-3,000
| -7% | -$42.9K | 0.02% | 249 |
|
|
2022
Q3 | $1.1M | Sell |
43,000
-2,000
| -4% | -$51.1K | 0.06% | 216 |
|
|
2022
Q2 | $1.28M | Buy |
+45,000
| New | +$1.28M | 0.06% | 198 |
|